论文部分内容阅读
慢性粒细胞白血病(CML)是造血干细胞恶性克隆增殖性疾病,血液科常见。曾经应用马利兰、联合化疗等方法,疾病能够有所控制。目前羟基脲(HU)及α-干扰素(α-IFN)的联合应用,为CML患者提供了新的治疗途径,现将我院1998年10月至2008年6月应用HU+α-IFN治疗CML132例疗效观察报告如下
Chronic myeloid leukemia (CML) is a proliferative disease of hematopoietic stem cell malignant clone, hematology is common. Once the application of Maryland, combined with chemotherapy and other methods, the disease can be controlled. At present, the combined application of hydroxyurea (HU) and alpha-interferon (IFN-α) provides a new therapeutic approach for patients with CML. The treatment of HU + α-IFN in our hospital from October 1998 to June 2008 CML132 cases of efficacy report is as follows